<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="689">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05152186</url>
  </required_header>
  <id_info>
    <org_study_id>blood loss in spine surgery</org_study_id>
    <nct_id>NCT05152186</nct_id>
  </id_info>
  <brief_title>Compare Between the Effect of Topical Tranexamic Acid Versus Hydrogen Peroxide on Blood Loss in Spine Surgeries</brief_title>
  <acronym>Bloodloss</acronym>
  <official_title>Comparison Between the Effect of Topical Tranexamic Acid Versus Hydrogen Peroxide on Perioperative Blood Loss in Elective Spine Surgeries</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Minia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Minia University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To evaluate the effectiveness of topical TXA in reducing blood loss compared to H2O2 wash.&#xD;
&#xD;
      The primary outcomes :&#xD;
&#xD;
        1. Estimation of Intraoperative blood loss and blood transfusion.&#xD;
&#xD;
        2. Recording Postoperative blood drainage.&#xD;
&#xD;
        3. Comparing Hemoglobin levels (pre and postoperative).&#xD;
&#xD;
      The secondary outcomes :&#xD;
&#xD;
        1. Surgical site infection (SSI)&#xD;
&#xD;
        2. Length of hospital stay.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Spinal surgery is one of the most commonly performed neuro-surgeries worldwide. Massive blood&#xD;
      loss occurs frequently and remains a challenge in complex spinal surgery. Significant intra&#xD;
      and postoperative hemorrhage negatively affects patient outcomes by increasing coagulopathy,&#xD;
      postoperative hematoma and anemia .The need for allogenic blood transfusions can lead to&#xD;
      potential transfusion reactions and infections, in addition to increasing long-term mortality&#xD;
      rates. There is an economic disadvantage associated with iatrogenic major blood loss relating&#xD;
      to the direct costs of the blood products and intraoperative blood salvage technology and&#xD;
      indirect costs of prolonged patient hospitalization and complication management .&#xD;
&#xD;
      Many efforts have focused on achieving better perioperative blood conservation, in particular&#xD;
      through prophylactic intravenous administration of antifibrinolytic agents before and during&#xD;
      major surgery. Intravenous administration of the inexpensive but highly effective drug as&#xD;
      tranexamic acid (TXA) reduces perioperative hemorrhage and the need for blood transfusions by&#xD;
      one third in major surgery, including spinal surgery, Included on the list of the World&#xD;
      Health Organization (WHO) List of Essential Medicines, TXA has taken its place as a widely&#xD;
      used hemostatic agent in the clinical setting .&#xD;
&#xD;
      Tranexamic acid is a synthetic analog of the amino acid lysine. It serves as an&#xD;
      antifibrinolytic by reversibly binding four to five lysine receptor sites on plasminogen.&#xD;
      This reduces conversion of plasminogen to plasmin, preventing fibrin degradation and&#xD;
      preserving the framework of fibrin's matrix structure .Tranexamic acid has roughly eight&#xD;
      times the antifibrinolytic activity of an older analogue, Îµ-aminocaproic acid. Tranexamic&#xD;
      acid also directly inhibits the activity of plasmin with weak potency .&#xD;
&#xD;
      Hydrogen peroxide (H2O2) is an inexpensive and readily available option whose hemostatic and&#xD;
      antiseptic properties have been separately confirmedin several previous studies .&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Actual">November 1, 2021</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Blood loss estimation [NCT ID not yet assigned]</measure>
    <time_frame>Within 48 hours</time_frame>
    <description>Estimation of perioperative blood loss and need of blood transfusion, lab investigations pre and postoperative (hemoglobin (gm/dL), hematocrit (%), Prothrombin concentration (%), INR, platelets).&#xD;
Recording Postoperative blood drainage (in ml). and Comparing Hemoglobin levels (pre and postoperative).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications</measure>
    <time_frame>7 days</time_frame>
    <description>Anaemia secondary to blood loss, surgical site infection , length of hospital stay (in days), complications of drugs used in procedure.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">120</enrollment>
  <condition>Blood Loss</condition>
  <arm_group>
    <arm_group_label>tranexamic acid</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical hemostatics as tranexamic acid or hydrogen peroxide in wound before skin closure to decrease perioperative blood loss</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Hydrogen peroxide</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Topical hemostatics as hydrogen peroxide in wound before skin closure to decrease perioperative blood loss</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Hemostasis in spine surgery</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical Solution</intervention_name>
    <description>Topical administration</description>
    <arm_group_label>Hydrogen peroxide</arm_group_label>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_label>tranexamic acid</arm_group_label>
    <other_name>Irrigation</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Topical Foam</intervention_name>
    <description>Topical administration</description>
    <arm_group_label>Hydrogen peroxide</arm_group_label>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_label>tranexamic acid</arm_group_label>
    <other_name>Disinfectant</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Topical</intervention_name>
    <description>Topical administration</description>
    <arm_group_label>Hydrogen peroxide</arm_group_label>
    <arm_group_label>Normal saline</arm_group_label>
    <arm_group_label>tranexamic acid</arm_group_label>
    <other_name>Crystalloid</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASA: class II or III&#xD;
&#xD;
          -  Sex: male and female&#xD;
&#xD;
          -  Age: from 20 to 70 years.&#xD;
&#xD;
          -  Type of operation: patient will undergo spinal surgery with a diagnosis of in place&#xD;
             spinal trauma, thoracic or lumbar degenerative disease, such as spinal canal stenosis,&#xD;
             disc herniation, spondylolisthesis, and/or degenerative scoliosis under general&#xD;
             anesthesia.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients with history of thromboembolic disease or coagulopathy or hereditary bleeding&#xD;
             disorders such as factor VIII deficiency, factor IX deficiency, and Von-Willebrand&#xD;
             disease.&#xD;
&#xD;
          -  Patients who were taking anticoagulants or antiplatelet drugs.&#xD;
&#xD;
          -  Allergy or hypersensitivity to TXA.&#xD;
&#xD;
          -  A dural tear accompanied by cerebrospinal fluid leakage detected intraoperatively.&#xD;
&#xD;
          -  Spinal cord tumors, head trauma and penetrating spinal cord trauma.&#xD;
&#xD;
          -  The use of intravenous TXA during the perioperative period .&#xD;
&#xD;
          -  Infection at the operative site e.g T.B.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <gender_based>Yes</gender_based>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amani Khairy, Professor</last_name>
    <role>Study Chair</role>
    <affiliation>Faculty of Medicine, Minia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Sarah Mohamed, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Medicine, Minia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Walid Zidan, Lecturer</last_name>
    <role>Study Director</role>
    <affiliation>Faculty of Medicine, Minia University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nehal Kamal, Master</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faulty of medicine, Minia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Minia University hospital</name>
      <address>
        <city>Minya</city>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Qureshi R, Puvanesarajah V, Jain A, Hassanzadeh H. Perioperative Management of Blood Loss in Spine Surgery. Clin Spine Surg. 2017 Nov;30(9):383-388. doi: 10.1097/BSD.0000000000000532. Review.</citation>
    <PMID>28338491</PMID>
  </reference>
  <reference>
    <citation>Hui S, Peng Y, Tao L, Wang S, Yang Y, Du Y, Zhang J, Zhuang Q; TARGETS study group. Tranexamic acid given into wound reduces postoperative drainage, blood loss, and hospital stay in spinal surgeries: a meta-analysis. J Orthop Surg Res. 2021 Jun 22;16(1):401. doi: 10.1186/s13018-021-02548-6.</citation>
    <PMID>34158096</PMID>
  </reference>
  <verification_date>December 2021</verification_date>
  <study_first_submitted>November 12, 2021</study_first_submitted>
  <study_first_submitted_qc>December 7, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">December 9, 2021</study_first_posted>
  <last_update_submitted>December 7, 2021</last_update_submitted>
  <last_update_submitted_qc>December 7, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">December 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Minia University</investigator_affiliation>
    <investigator_full_name>Nehal Kamal Mohamed</investigator_full_name>
    <investigator_title>Assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Blood loss</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disinfectants</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

